These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 5879)

  • 21. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.
    Welton AF; Hope WC; O'Donnell M; Baruth H; Crowley HJ; Miller DA; Yaremko B
    J Pharmacol Exp Ther; 1984 Jan; 228(1):57-64. PubMed ID: 6198511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release.
    Fleisch JH; Haisch KD; Spaethe SM; Rinkema LE; Cullinan GJ; Schmidt MJ; Marshall WS
    J Pharmacol Exp Ther; 1984 Jun; 229(3):681-9. PubMed ID: 6202867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Slow reacting substance as a preformed mediator from human lung.
    Turnbull LS; Jones DG; Kay AB
    Immunology; 1976 Nov; 31(5):813-20. PubMed ID: 11180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computerization of a bioassay: quantitation of slow reacting substance of anaphylaxis (SRS-A).
    Fleisch JH; Zaborowsky BR; Cerimele BJ; Spaethe SM
    J Pharmacol Exp Ther; 1979 May; 209(2):238-43. PubMed ID: 86610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The release of four mediators of immediate hypersensitivity from human leukemic basophils.
    Lewis RA; Goetzl EJ; Wasserman SI; Valone FH; Rubin RH; Austen KF
    J Immunol; 1975 Jan; 114(1 Pt 1):87-92. PubMed ID: 46247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
    Yamamura H; Kohno S; Ohata K
    Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are the leukotrienes involved in the bronchial asthma?
    Votava Z
    Biomed Biochim Acta; 1984; 43(8-9):S434-7. PubMed ID: 6517906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cells and asthma. The role of mast cell mediators in the pathogenesis of allergic asthma.
    Casale TB; Marom Z
    Ann Allergy; 1983 Jul; 51(1 Pt 1):2-6. PubMed ID: 6307082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of histamine in asthma].
    Parrot JL; Mordelet M; Santais MC; Ruff F
    Allergol Immunopathol (Madr); 1976; 4(2):153-6. PubMed ID: 59539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Leukotrienes and the lung].
    Leitch AG
    Rev Mal Respir; 1984; 1(6):329-36. PubMed ID: 6099600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of human eosinophil polymorphonuclear leukocyte migration and function.
    Goetzl EJ
    Am J Pathol; 1976 Nov; 85(2):419-36. PubMed ID: 793410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cinnarizine on IgE antibody-mediated experimental allergic reactions in guinea pigs.
    Nagai H; Yamada H; Yakuo I; Inagaki N; Choi SH; Koda A; Daikoku M
    Allergy; 1987 Feb; 42(2):135-40. PubMed ID: 2438961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat.
    Stechschulte DJ; Austen KF; Bloch KJ
    J Exp Med; 1967 Jan; 125(1):127-47. PubMed ID: 4163357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KC-404: a potential anti-allergic agent with antagonistic action against slow reacting substance of anaphylaxis.
    Nishino K; Ohkubo H; Ohashi M; Hara S; Kito J; Irikura T
    Jpn J Pharmacol; 1983 Apr; 33(2):267-78. PubMed ID: 6193303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anaphylaxis in chopped guinea pig lung. II. Enhancement of the anaphylactic release of histamine and slow reacting substance by certain dibasic aliphatic acids and inhibition by monobasic fatty acids.
    AUSTEN KF; BROCKLEHURST WE
    J Exp Med; 1961 Mar; 113(3):541-57. PubMed ID: 13685195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An eosinophil leukocyte chemotactic factor of anaphylaxis.
    Kay AB; Stechschulte DJ; Austen KF
    J Exp Med; 1971 Mar; 133(3):602-19. PubMed ID: 4106805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological studies on the release of slow reacting substance of anaphylaxis during anti-immunoglobulin E antibody mediated passive peritoneal anaphylaxis in rats.
    Nagai H; Yamada H; Matsuura N; Iwamoto T; Choi SH; Koda A
    J Pharmacobiodyn; 1987 Jan; 10(1):49-54. PubMed ID: 3108486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of a new corticosteroid, budesonide, on anaphylactic bronchoconstriction and SRS-A release in the guinea pig.
    Forsberg K; Sörenby L
    Agents Actions; 1981 Jul; 11(4):391-5. PubMed ID: 6169265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The release of spasmogenic substances from human chopped lung tissue and its inhibition.
    Piper PJ; Walker JL
    Br J Pharmacol; 1973 Feb; 47(2):291-304. PubMed ID: 4352867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.